Biocon Gets FDA Observations At Key Biosimilars Facilities

US Agency Finds Multiple Form 483 Deficiencies Across Bengaluru And Malaysia Sites

483 3D numbers green background
Biocon has received multiple Form 483 observations across three facilities • Source: Shutterstock

More from Manufacturing

More from Business